Related Experiment Video
Updated: Jun 3, 2026
11:06
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Phytosterols and phytosterolemia: gene-diet interactions.
Maria C Izar1, Daniela M Tegani, Soraia H Kasmas
1Cardiology Division, Department of Medicine, Federal University of Sao Paulo, Sao Paulo, UNIFESP, Rua Pedro de Toledo 276, 04039-030 São Paulo, SP Brazil.
Genes & Nutrition
|March 26, 2011
Summary
Plant sterols lower cholesterol absorption via the NPC1L1 pathway but can increase in plasma with certain treatments. Understanding gene-diet interactions is key to managing sterol levels and hypolipidemic drug responses.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Phytosterols are adjunctive therapies for hypercholesterolemia, reducing cholesterol absorption via the NPC1L1 transporter.
- Phytosterol absorption is less than cholesterol and efficiently secreted by ABCG5/G8 transporters, resulting in low plasma levels.
- Controversy exists regarding statin-induced increases in non-cholesterol sterols and phytosterol safety.
Purpose of the Study:
- To discuss mechanisms of cholesterol and phytosterol absorption and whole-body sterol pools.
- To explore concerns about phytosterol supplementation with statins and increased phytosterols from enriched foods.
- To examine the role of ABCG5/G8 transporter mutations (sitosterolemia) and ezetimibe's effects on phytosterolemia and xanthomas.
Main Methods:
- Literature review and discussion of sterol absorption pathways.
- Analysis of transporter mechanisms (NPC1L1, ABCG5/G8) in sterol metabolism.
- Exploration of genetic variations (polymorphisms, mutations) and their impact on drug response.
Main Results:
- Phytosterols compete with cholesterol for absorption via NPC1L1.
- ABCG5/G8 transporters facilitate phytosterol secretion, limiting plasma accumulation.
- Ezetimibe reduces phytosterolemia; NPC1L1 polymorphisms can affect ezetimibe efficacy.
- Rare ABCG5/G8 mutations cause sitosterolemia; common polymorphisms influence NPC1L1 function.
Conclusions:
- Gene-diet interactions significantly modulate sterol metabolism and response to hypolipidemic treatments.
- Understanding these interactions is crucial for personalized lipid-lowering strategies.
- Further research is warranted to elucidate the complex interplay of genetics, diet, and drug efficacy.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:28Overview of Fatty Acid Metabolism
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...